Quantification of Circulating TCR-Engineered T Cells Targeting a Human Endogenous Retrovirus Post-Adoptive Transfer Using Nanoplate Digital PCR

0
32
Investigators developed and evaluated the feasibility and performance of nanoplate-based digital PCR to quantify adoptively infused T cells engineered with a TCR that recognizes a HERV-E antigen.
[Molecular Therapy-Methods & Clinical Development]
Abstract